Contrôles Essais Mesures
vendredi 24 mars 2023
  • Find out!
  • Receive our newsletter
  • Contact us
  • English
  • Français
  • Articles
    • Measures
    • Non destructive testing
    • Optical
    • Automatisms
    • Industrial data
    • Management
    • Type d’info
      • Market Info
      • Product Info
  • Expert opinions
  • Agenda
  • Spotlight
  • Podcasts
    • Metrolaudio
    • Questions de métrologie
    • 3 questions for ...
    • Editos
  • Kit media
No result
See all results
  • Articles
    • Measures
    • Non destructive testing
    • Optical
    • Automatisms
    • Industrial data
    • Management
    • Type d’info
      • Market Info
      • Product Info
  • Expert opinions
  • Agenda
  • Spotlight
  • Podcasts
    • Metrolaudio
    • Questions de métrologie
    • 3 questions for ...
    • Editos
  • Kit media
No result
See all results
Contrôles Essais Mesures
No result
See all results
Home Non destructive testing

AI for a more objective skin analysis

By Contrôles Essais Mesures
12 October 2021
in Non destructive testing
Reading time: 3 min
Share on LinkedInShare on FacebookShare on twitter

Archos announces the creation of Poladerme, currently 40% owned by Medical Devices Venture1,a subsidiary of Archos whose objective is to develop a portfolio of stakes in the field of new health technologies.

The ambition of the startup Poladerme is to become a leader in spectropolarimetry combined with artificial intelligence and machine learning, applied to dermatology.

The company Poladerme, matured by Conectus, the Satt (Société d'accélération du transfert de technologies) of Strasbourg, is developing an innovative, fast and non-invasive diagnostic aid solution, based on an optical system and artificial intelligence algorithms to deeply analyze tissues and assess the state of health of the skin2.

A company born of research

In the ICube laboratory at the University of Strasbourg, France, Professors Jihad Zallat and Christian Heinrich have been conducting research on spectropolarimetry and image processing and analysis techniques for more than 10 years in the Trio and Images research teams. The biomedical field is the preferred application framework.

The two researchers collaborated closely with partners biologists, doctors and dermatology researchers, including strong interactions with Inserm and the dermatology department of the University Hospitals of Strasbourg. With a scientific relevance validated by publications and based on a clinical study3, and the achievement of a point of maturity to transfer this approach into a medical device, Medical Devices Venture participated in the creation of the company Poladerme to support it in the industrialization and commercialization of its solution.

Cutting-edge technology at the service of dermatology

The skin occupies a fundamental place in the health and well-being of body and mind. Indeed the skin, the largest organ of the body, is the revealer of many diseases and is prone to premature aging.

The dermatoscope, a skin analysis tool used today, is based on the magnifying glass, a technology that dates back to the 11th century.

Poladerme demonstrates that skin analysis will involve a new technology, namely spectropolarimetry and artificial intelligence algorithms. A source of significant improvement in the daily lives of healthcare professionals and patients, this new technology will allow, through its wide dissemination, a reduction in analysis times as well as a more objective reading, thus reducing the field left to interpretation, richer and deeper lesions.

Spectropolarimetry is a very promising modality for the detection and diagnosis of cancer. A contrast between healthy and diseased tissues has been found in a wide variety of human organs. Polarization is a powerful tool because it allows you to explore various aspects of tissue organization. It is sensitive to birefringent structures such as collagen and muscle fibers, myelin and keratin, as well as to disruptions in tissue structure via depolarization. Then, using global statistical models based on decision theory, the Poladerme system will propose a classification of the sample associated with a confidence level.

The Poladerme solution will be available in the first half of 2022.

1 It is stated that under the terms of an investment protocol concluded between Poladerme's partners on 9 September 2021, Medical Devices Venture will hold 53.3% of Poladerme's capital following a capital increase to be carried out by 31 December 2021 at the latest.
2 The technology developed by the researchers is granted to Poladerme by Satt Conectus under an exclusive licence.
3 Finalized clinical study scheduled for publication in early 2022

For more information:
www.archos.com

Labels: Product Info
Previous article

Artificial Intelligence Evaluation Forum

Next article

Trescal acquires Broadview Instrumentation Services and the calibration business of Sudel Industries

Related articles

Non destructive testing

NDT/SHM simulation and analysis: new version of the Civa software

Civa 2023 brings: a new Aut-Pipeline module, a new Data Science environment, a significant evolution of the SHM module, new phase consistency algorithms in TFM UT reconstruction, new phase coherence algorithms in TFM UT reconstruction,...

By Writing
17 mars 2023
Non destructive testing

The Cofrend Days are in the starting blocks

Six long years that the NDT "family" had not been able to come together and celebrate innovation. It will be done from June 6 to 8 at Parc Chanot in Marseille for the...

By Contrôles Essais Mesures
16 mars 2023
Non destructive testing

[EMC 82] Non-destructive testing adapts to composite inspection

The replacement of metals by composite materials aims to lighten parts while natively endowing them with new functionalities. The manufacturing quality of composite parts...

By Contrôles Essais Mesures
February 20, 2023
Non destructive testing

Technical day: NDT solutions for monitoring in-service equipment

On March 16, 2023, from 09:00 to 16:15, in Villepinte, the Industrial Members Department of the Institut de Soudure is organizing a technical day on the theme: "Means of control in service"....

By Writing
February 16, 2023
Non destructive testing

Extech takes indoor air quality monitoring to the next level

Extech's new 42280A Series Temperature and Humidity Data Logger features a number of notable improvements over the company's older model that is experiencing a new model.

By Writing
January 26, 2023
Non destructive testing

Monitoring and observation of radioactive waste storage: Andra and LNE renew their agreement

On Tuesday, January 10, 2023, Pierre-Marie Abadie, Director General of the National Agency for Radioactive Waste Management (Andra) and Thomas Grenon, Director General of the National Metrology and Radioactive Waste Management Laboratory...

By Writing
January 25, 2023
Next article

Trescal acquires Broadview Instrumentation Services and the calibration business of Sudel Industries

Our latest issue

For more feature articles, subscribe to Contrôles Essais Mesures magazine.

Spotlight

Advertising

Newsletter

Receive free information from the Contrôles Essais Mesures website with each publication

You can unsubscribe at any time. Your data is processed according to our privacy policy.

Thank you !

Please now check your inbox or junk folder to confirm your subscription.

.

Our partners

Contrôles Essais Mesures

© 2021 Contrôles Essais Mesures, the technology and application review for laboratories and industry.

You want ?

  • Contact
  • Who are we ?
  • Become an advertiser
  • Sitemap
  • Legal Notice
  • Data protection
  • Unsubscribe from the newsletter

Follow us

No result
See all results
  • Item categories
    • Measures
    • Non destructive testing
    • Optical
    • Automatisms
    • Management
  • Expert opinions
  • Magazine
    • Presentation
    • Kit media 2021
  • Agenda
  • Spotlight
  • Podcasts
    • Metrolaudio
    • Questions de métrologie
    • 3 questions for ...
    • Editos
  • Contact
  • English
  • Français

© 2021 Contrôles Essais Mesures, the technology and application review for laboratories and industry.

Ce site utilise des cookies. Vous pouvez visiter notre politique de protection ds données personnelles pour en savoir plus.
X